Predictors of Progression Free Survival, Overall Survival and Early Cessation of Chemotherapy in Women with Potentially Platinum Sensitive (PPS) Recurrent Ovarian Cancer (ROC) Starting Third or Subsequent Line(≥3) Chemotherapy – the GCIG Symptom Benefit Study (SBS)
Gynecologic Oncology(2019)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要